SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer
- PMID: 31090082
- DOI: 10.1002/pros.23830
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer
Abstract
Background: ERG fusion-related prostate cancer (PrCa) is the most prevalent oncogenic driver subclass. SPOP, FOXA1, and IDH1 mutations are other three main oncogenic driver subclasses in non-ETS-fusion PrCa. ERG protein levels seem to be increased in SPOP-mutated cases, and different studies reported that SPOP mutations and ERG fusions are mutually exclusive. The aim of this study has been to analyze the alterations in non-ETS-oncogenic drivers in PrCa.
Methods: SPOP, FOXA1, and IDH mutations were investigated by polymerase chain reaction (PCR) and Sanger direct sequencing. ERG, SPOP, and TMPRSS2-ERG messenger RNA expression was assessed by quantitative real-time PCR from complementary DNA, and the presence of the fusion was also analyzed by nonquantitative PCR. The clinical pathological features were retrieved from the charts of the 111 patients included in the study (MARBiobanc, Barcelona, Spain).
Results: Loss of SPOP expression (25.2%) was associated with ERG overexpression (P = 0.0036). SPOP mutations were found in 5.4% cases, all with wild-type (wt) ERG (P = 0.007). FOXA1 mutations were found in 8.2% cases, most of them ERG wt (P = 0.06). No IDH1 mutations were found. SPOP or FOXA1 mutations were found in 1.7% of ERG-rearranged, and 34.2% of non-ERG-rearranged cases (P < 0.0001). SPOP or FOXA1 alterations (mutations or expression loss) were significantly more common in GG5, while isolated ERG overexpression was more common in GG1 tumors (P = 0.042). SPOP-or FOXA1-mutated cases were associated with a shorter time to prostate-specific antigen (PSA) recurrence in the univariate (P = 0.0009), and with the PSA recurrence risk in the multivariate (P = 0.023) analysis.
Conclusions: In conclusion, SPOP and FOXA1 mutations may have prognostic value in ERG wt tumors. Interestingly, in absence of SPOP mutations, downregulation of this gene is a feature of many ERG-rearranged prostate tumors.
Keywords: ERG; FOXA1; SPOP; grade group; prostate cancer; prostate-specific antigen recurrence.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.Prostate. 2021 Dec;81(16):1267-1277. doi: 10.1002/pros.24218. Epub 2021 Sep 17. Prostate. 2021. PMID: 34533858
-
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy.Carcinogenesis. 2017 Dec 7;38(12):1180-1187. doi: 10.1093/carcin/bgx105. Carcinogenesis. 2017. PMID: 29029032
-
Determination of TMPRSS2-ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis.Cell Biol Int. 2023 May;47(5):1017-1030. doi: 10.1002/cbin.12000. Epub 2023 Feb 5. Cell Biol Int. 2023. PMID: 36740223
-
The Genomics of Prostate Cancer: emerging understanding with technologic advances.Mod Pathol. 2018 Jan;31(S1):S1-11. doi: 10.1038/modpathol.2017.166. Mod Pathol. 2018. PMID: 29297493 Review.
-
The emerging role of speckle-type POZ protein (SPOP) in cancer development.Drug Discov Today. 2014 Sep;19(9):1498-502. doi: 10.1016/j.drudis.2014.07.009. Epub 2014 Jul 21. Drug Discov Today. 2014. PMID: 25058385 Free PMC article. Review.
Cited by
-
FOXA1 in prostate cancer.Asian J Androl. 2023 May-Jun;25(3):287-295. doi: 10.4103/aja202259. Asian J Androl. 2023. PMID: 36018068 Free PMC article. Review.
-
Phosphorylation-dependent regulation of SPOP by LIMK2 promotes castration-resistant prostate cancer.Br J Cancer. 2021 Mar;124(5):995-1008. doi: 10.1038/s41416-020-01197-6. Epub 2020 Dec 14. Br J Cancer. 2021. PMID: 33311589 Free PMC article.
-
The Genetic Complexity of Prostate Cancer.Genes (Basel). 2020 Nov 25;11(12):1396. doi: 10.3390/genes11121396. Genes (Basel). 2020. PMID: 33255593 Free PMC article. Review.
-
S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression.Mol Ther Oncolytics. 2020 Oct 4;19:149-162. doi: 10.1016/j.omto.2020.09.008. eCollection 2020 Dec 16. Mol Ther Oncolytics. 2020. PMID: 33209975 Free PMC article.
-
Molecular Interplay between AURKA and SPOP Dictates CRPC Pathogenesis via Androgen Receptor.Cancers (Basel). 2020 Nov 4;12(11):3247. doi: 10.3390/cancers12113247. Cancers (Basel). 2020. PMID: 33158056 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous